Superficial Multicentric Basal Cell Carcinoma

Superficial multicentric basal cell carcinoma (SMcBCC) is a type of skin cancer that affects the basal cells in the outermost layer of the skin. It’s essential to grasp the basics of this condition, including its types, causes, symptoms, diagnostic methods, treatment options, and medications. In this article, we’ll break down the information into simple language to help you understand SMcBCC better.

Types of Superficial Multicentric Basal Cell Carcinoma:

1. Superficial Basal Cell Carcinoma (sBCC): This type appears as red, scaly patches and usually grows slowly.
2. Nodular Basal Cell Carcinoma (nBCC): It presents as a firm, shiny bump and tends to grow more rapidly than sBCC.
3. Infiltrative Basal Cell Carcinoma (iBCC): iBCC infiltrates deeper into the skin, often appearing as a scar-like spot.
4. Morpheaform Basal Cell Carcinoma (mBCC): mBCC has a waxy, white, or yellow appearance and may be difficult to distinguish from normal skin.

Causes of Superficial Multicentric Basal Cell Carcinoma:

1. Ultraviolet (UV) Radiation Exposure: Prolonged exposure to UV rays from the sun or tanning beds is a primary risk factor.
2. Fair Skin: People with fair skin, especially those who burn easily, are more susceptible.
3. Family History: A family history of skin cancer can increase your risk.
4. Age: SMcBCC is more common in older individuals.
5. Weakened Immune System: Conditions that weaken the immune system, such as HIV/AIDS or organ transplants, can raise the risk.
6. Radiation Exposure: Previous radiation treatments can contribute to the development of SMcBCC.
7. Chemical Exposure: Exposure to certain chemicals like arsenic can be a factor.
8. Chronic Skin Inflammation: Conditions like psoriasis or scars from burns may increase the risk.
9. Xeroderma Pigmentosum (XP): This rare genetic disorder makes the skin highly sensitive to UV rays, increasing the risk of SMcBCC.
10. Personal History: If you’ve had basal cell carcinoma before, you are at a higher risk of developing it again.
11. Gender: Men are more likely to develop SMcBCC than women.
12. Geographical Location: Living in areas with intense sunlight can increase the risk.
13. HPV Infection: Certain strains of the human papillomavirus (HPV) may be linked to SMcBCC.
14. Ionizing Radiation: Exposure to ionizing radiation, such as X-rays, can be a contributing factor.
15. Immunosuppressive Medications: Some medications used to suppress the immune system may raise the risk.
16. Chronic Skin Infections: Long-term skin infections may increase susceptibility.
17. Gorlin-Goltz Syndrome: This rare genetic disorder increases the risk of developing multiple BCCs.
18. Bazex-Dupré-Christol Syndrome: Another rare genetic disorder associated with BCC development.
19. Gardner Syndrome: A genetic disorder that predisposes individuals to various cancers, including SMcBCC.
20. Lupus: Systemic lupus erythematosus (SLE) may increase the risk of SMcBCC.

Symptoms of Superficial Multicentric Basal Cell Carcinoma:

1. Reddish Patches: sBCC often appears as flat, red, scaly patches on the skin.
2. Shiny Bumps: nBCC presents as shiny, raised bumps, often with visible blood vessels.
3. Scar-Like Lesions: iBCC may resemble scars, with a slightly depressed, firm texture.
4. Waxy Spots: mBCC can look like waxy, white or yellowish spots that are hard to differentiate from normal skin.
5. Ulceration: In advanced cases, SMcBCC can develop open sores that don’t heal.
6. Bleeding or Crusting: Lesions may bleed or form crusts.
7. Oozing or Discharge: Some SMcBCC lesions may ooze or produce a discharge.
8. Itchiness or Pain: Lesions can become itchy or painful.
9. Change in Appearance: Keep an eye on any spots that change in size, color, or shape.
10. Slow Growth: Most SMcBCC lesions grow slowly, which can make them easy to overlook.
11. Invasion of Nearby Tissues: Invasive cases may extend into surrounding tissues or structures.
12. Enlarged Blood Vessels: Some lesions may have prominent blood vessels.
13. Visible Borders: Lesions often have well-defined borders.
14. Loss of Eyelashes or Distorted Ear Structure: In rare cases on the face, SMcBCC can cause eyelash loss or distortion of the ear.
15. Facial Disfigurement: If left untreated, SMcBCC on the face can lead to disfigurement.
16. Numbness: Invasive SMcBCC may cause numbness in affected areas.
17. Bone Erosion: In very rare cases, SMcBCC can erode underlying bones.
18. Difficulty Swallowing or Breathing: For lesions in the throat or neck area, symptoms may include difficulty swallowing or breathing.
19. Persistent Cough: When SMcBCC affects the lungs, it can cause a persistent cough.
20. Hoarseness: Throat involvement may lead to hoarseness or changes in voice quality.

Diagnostic Tests for Superficial Multicentric Basal Cell Carcinoma:

1. Skin Biopsy: A small piece of the lesion is removed and examined under a microscope to confirm the diagnosis.
2. Dermoscopy: A dermatoscope is used to examine the lesion’s features in detail.
3. Confocal Microscopy: This non-invasive imaging technique provides high-resolution images of skin layers.
4. Immunohistochemistry: Special stains are used to detect specific proteins in the biopsy sample.
5. CT Scan: For advanced cases, a CT scan may be used to assess the extent of the cancer.
6. MRI: Magnetic resonance imaging can provide detailed images of the affected area.
7. Ultrasound: Used to assess the depth and size of lesions.
8. PET Scan: Positron emission tomography can help determine if the cancer has spread.
9. Sentinel Lymph Node Biopsy: If lymph nodes are affected, a biopsy may be performed to check for cancer cells.
10. Blood Tests: Blood tests may be done to assess overall health and liver function.
11. X-rays: X-rays can help determine if the cancer has spread to the bones.
12. Endoscopy: For lesions in the throat or digestive tract, an endoscope may be used to visualize the area.
13. Bone Scan: To check for bone involvement in advanced cases.
14. Genetic Testing: In cases of Gorlin-Goltz, Bazex-Dupré-Christol, or Gardner syndromes, genetic testing may be recommended.
15. Molecular Testing: Molecular tests can help determine the most suitable treatment options.
16. Fine Needle Aspiration (FNA): Used to sample suspicious lymph nodes.
17. Biopsy of Adjacent Structures: If the cancer has invaded nearby structures, a biopsy may be necessary.
18. Lymph Node Imaging: Techniques like lymphoscintigraphy can assess lymph node involvement.
19. Cytology Exam: Cells from the lesion may be examined under a microscope.
20. Histopathology: Detailed examination of tissue samples to determine the specific subtype of SMcBCC.

Treatments for Superficial Multicentric Basal Cell Carcinoma:

1. Excisional Surgery: The lesion is cut out along with a margin of healthy tissue.
2. Mohs Surgery: A specialized technique that removes layers of tissue until no cancer cells remain.
3. Cryotherapy: Freezing the lesion with liquid nitrogen to destroy cancer cells.
4. Electrodesiccation and Curettage: The lesion is scraped away and then burned with an electric current.
5. Radiation Therapy: High-energy rays target and kill cancer cells.
6. Topical Medications: Creams or gels containing medications like imiquimod or 5-fluorouracil may be applied directly to the lesion.
7. Photodynamic Therapy (PDT): A light-sensitive drug is applied to the lesion and activated with light to destroy cancer cells.
8. Laser Therapy: A focused beam of light is used to vaporize the lesion.
9. Oral Medications: In some cases, oral medications like vismodegib or sonidegib may be prescribed for advanced SMcBCC.
10. Intralesional Injection: Medications may be injected directly into the lesion.
11. Targeted Therapy: Drugs that target specific molecular pathways in cancer cells.
12. Immunotherapy: Stimulates the immune system to attack cancer cells.
13. Chemotherapy: In rare cases, systemic chemotherapy may be used.
14. Lymph Node Dissection: For advanced cases involving lymph nodes, surgical removal may be necessary.
15. Palliative Care: Focuses on relieving symptoms and improving the quality of life in advanced cases.
16. Reconstruction Surgery: After tumor removal, reconstructive surgery may be needed to restore appearance and function.
17. Artificial Eye: For cases involving the eye, an artificial eye may be necessary.
18. Voice Therapy: In cases affecting the throat, voice therapy can help restore speech.
19. Bone Reconstruction: In cases involving bone erosion, reconstructive surgery may be required.
20. Chemoradiation: Combining chemotherapy and radiation therapy for aggressive SMcBCC.

Drugs Used in Superficial Multicentric Basal Cell Carcinoma:

1. Imiquimod (Aldara): A topical cream that stimulates the immune system to attack cancer cells.
2. 5-Fluorouracil (Efudex): A topical cream that interferes with cancer cell growth.
3. Vismodegib (Erivedge): An oral medication that targets specific pathways in cancer cells.
4. Sonidegib (Odomzo): Another oral medication that inhibits cancer cell growth.
5. Methotrexate: In rare cases, this chemotherapy drug may be used.
6. Cetuximab (Erbitux): An immunotherapy drug that targets certain proteins in cancer cells.
7. Interferon: An immune system stimulant that may be used in some cases.
8. Aldesleukin (Proleukin): An immunotherapy drug used in advanced cases.
9. Cisplatin: A chemotherapy drug that may be used in combination with radiation therapy.
10. Topical Calcineurin Inhibitors: Tacrolimus and pimecrolimus may be used topically in certain cases.
11. Panitumumab (Vectibix): An immunotherapy drug for some cases of advanced SMcBCC.
12. Bexarotene (Targretin): An oral medication that may be used in certain situations.
13. Dacarbazine: Chemotherapy drug used in rare cases.
14. Trametinib (Mekinist): A targeted therapy used in some advanced cases.
15. Nivolumab (Opdivo): An immunotherapy drug for specific cases.
16. Ipilimumab (Yervoy): Another immunotherapy option for advanced SMcBCC.
17. Talimogene Laherparepvec (Imlygic): An oncolytic virus therapy for some advanced cases.
18. Carboplatin: A chemotherapy drug used in combination with radiation therapy.
19. Pembrolizumab (Keytruda): An immunotherapy drug for specific cases.
20. Atezolizumab (Tecentriq): Another immunotherapy option for advanced SMcBCC.

Conclusion:

Superficial multicentric basal cell carcinoma is a skin cancer that can affect anyone, but certain risk factors make some individuals more susceptible. Recognizing the symptoms and seeking timely medical attention is crucial for successful treatment. A range of treatment options, from surgery to medications, are available depending on the extent and location of the cancer. It’s essential to consult with a healthcare professional for a personalized treatment plan tailored to your specific condition. With early detection and appropriate treatment, the prognosis for SMcBCC is generally favorable, emphasizing the importance of regular skin checks and sun protection to reduce the risk of developing this condition.

 

Disclaimer: Each person’s journey is unique, always seek the advice of a medical professional before trying any treatments to ensure to find the best plan for you. This guide is for general information and educational purposes only. If you or someone are suffering from this disease condition bookmark this page or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. Thank you for giving your valuable time to read the article.

References